However, proliferation (Ki-67) and activation (HLA-DR, CD69 and CD38) markers are significantly up-regulated on total CD8+ T cells in active SLE patients and less pronounced in inactive SLE patients compared to controls (Figures S3A–B in Text S1). Here, CD38 is linked to systemic lupus erythematosus.